查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1881432

內分泌檢測市場－全球產業規模、佔有率、趨勢、機會和預測，按檢測類型、技術、最終用戶、地區和競爭格局分類，2020-2030年預測

Endocrine Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Technology, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球內分泌檢測市場規模將從2024年的28.1億美元成長到2030年的46.9億美元，複合年成長率達8.92%。內分泌檢測涵蓋旨在評估內分泌系統功能的診斷程序，內分泌系統負責調節全身重要的荷爾蒙平衡。這些檢測透過測量各種生物樣本中的荷爾蒙水平，來診斷和監測糖尿病、甲狀腺疾病和腎上腺功能不全等疾病。

市場概覽
預測期 2026-2030
2024年市場規模 28.1億美元
2030年市場規模 46.9億美元
2025-2030年複合年成長率 8.92%
成長最快的細分市場 質譜分析
最大的市場 歐洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球內分泌檢測市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依檢測類型（雌二醇 (E2) 檢測、卵泡刺激素 (FSH) 檢測、人類絨毛膜促性腺激素 (hCG) 檢測、黃體生成素 (LH) 檢測、硫酸脫氫表雄酮 (DHEAS) 檢測、黃體素檢測、睪固酮檢測、促甲狀腺素 (TSH) 檢測、經胰島素檢測、其他素檢測、其他胰島素檢測）
    • 按技術分類（串聯質譜法、免疫分析法、單株和多株抗體抗體技術、感測器技術、臨床化學、其他）
    • 按最終使用者（醫院和診所、門診中心、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美內分泌檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲內分泌檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區內分泌檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲內分泌檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲內分泌檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球內分泌檢測市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • AB Sciex
  • bioMerieux SA
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd.
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Ortho Clinical Diagnostics

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 22157

The Global Endocrine Testing Market will grow from USD 2.81 Billion in 2024 to USD 4.69 Billion by 2030 at a 8.92% CAGR. Endocrine testing encompasses diagnostic procedures designed to evaluate the function of the endocrine system, which regulates essential hormonal balance throughout the body. These tests measure hormone levels in various biological samples to diagnose and monitor conditions such as diabetes, thyroid disorders, and adrenal insufficiency.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.81 Billion
Market Size 2030USD 4.69 Billion
CAGR 2025-20308.92%
Fastest Growing SegmentMass Spectroscopy
Largest MarketEurope

Key Market Drivers

The rising prevalence of endocrine disorders fundamentally drives the demand for diagnostic solutions. Conditions such as thyroid dysfunction, diabetes, and adrenal insufficiencies are increasingly widespread globally, necessitating accurate and timely identification for effective management and improved patient outcomes. This escalating burden translates directly into a greater need for comprehensive endocrine testing.

Key Market Challenges

The high cost associated with advanced testing technologies represents a significant impediment to the growth of the global endocrine testing market. This financial barrier directly restricts the widespread adoption of essential diagnostic procedures, particularly in developing regions where healthcare budgets are often limited. Smaller healthcare settings globally also face considerable challenges in acquiring and maintaining these expensive platforms, which consequently curtails their capacity to offer a comprehensive range of endocrine tests.

Key Market Trends

The growth of direct-to-consumer endocrine testing offerings is a significant market trend, enabling individuals to directly access diagnostic services without a traditional physician's referral. This paradigm shift democratizes access to health information, empowers patients in their wellness journeys, and fosters a proactive approach to health management. According to the American Diabetes Association's 2024 Annual Report, nearly 1 in 2 Americans has diabetes or prediabetes, collectively representing 136 million Americans living with these conditions.

Key Market Players

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • AB Sciex
  • bioMerieux SA
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd.
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Ortho Clinical Diagnostics

Report Scope:

In this report, the Global Endocrine Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Endocrine Testing Market, By Test Type:

  • Estradiol (E2) Test
  • Follicle Stimulating Hormone (FSH) Test
  • Human Chorionic Gonadotropin (hCG) Hormone Test
  • Luteinizing Hormone (LH) Test
  • Dehydroepiandrosterone Sulfate (DHEAS) Test
  • Progesterone Test
  • Testosterone Test
  • Thyroid Stimulating Hormone (TSH) Test
  • Prolactin Test
  • Cortisol Test
  • Insulin Test
  • Others

Endocrine Testing Market, By Technology:

  • Tandem Mass Spectrometry
  • Immunoassay
  • Monoclonal & Polyclonal Antibody Technologies
  • Sensor Technology
  • Clinical Chemistry
  • Others

Endocrine Testing Market, By End user:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Endocrine Testing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Endocrine Testing Market.

Available Customizations:

Global Endocrine Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Endocrine Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Cortisol Test, Insulin Test, Others)
    • 5.2.2. By Technology (Tandem Mass Spectrometry, Immunoassay, Monoclonal & Polyclonal Antibody Technologies, Sensor Technology, Clinical Chemistry, Others)
    • 5.2.3. By End user (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Endocrine Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type
    • 6.2.2. By Technology
    • 6.2.3. By End user
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Endocrine Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Test Type
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By End user
    • 6.3.2. Canada Endocrine Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Test Type
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By End user
    • 6.3.3. Mexico Endocrine Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Test Type
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By End user

7. Europe Endocrine Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By Technology
    • 7.2.3. By End user
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Endocrine Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By End user
    • 7.3.2. France Endocrine Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By End user
    • 7.3.3. United Kingdom Endocrine Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Test Type
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By End user
    • 7.3.4. Italy Endocrine Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Test Type
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By End user
    • 7.3.5. Spain Endocrine Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Test Type
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By End user

8. Asia Pacific Endocrine Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type
    • 8.2.2. By Technology
    • 8.2.3. By End user
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Endocrine Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By End user
    • 8.3.2. India Endocrine Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By End user
    • 8.3.3. Japan Endocrine Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By End user
    • 8.3.4. South Korea Endocrine Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test Type
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By End user
    • 8.3.5. Australia Endocrine Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test Type
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By End user

9. Middle East & Africa Endocrine Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type
    • 9.2.2. By Technology
    • 9.2.3. By End user
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Endocrine Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By End user
    • 9.3.2. UAE Endocrine Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test Type
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By End user
    • 9.3.3. South Africa Endocrine Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By End user

10. South America Endocrine Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type
    • 10.2.2. By Technology
    • 10.2.3. By End user
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Endocrine Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By End user
    • 10.3.2. Colombia Endocrine Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By End user
    • 10.3.3. Argentina Endocrine Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Endocrine Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Agilent Technologies Inc.
  • 15.3. Bio-Rad Laboratories Inc.
  • 15.4. AB Sciex
  • 15.5. bioMerieux SA
  • 15.6. DiaSorin S.p.A.
  • 15.7. F. Hoffmann-La Roche Ltd.
  • 15.8. Laboratory Corporation of America Holdings
  • 15.9. Quest Diagnostics Incorporated
  • 15.10. Ortho Clinical Diagnostics

16. Strategic Recommendations

17. About Us & Disclaimer